A Markov model to evaluate cost-effectiveness of antiangiogenesis therapy using bevacizumab in advanced cervical cancer

Journal article

L. E. Minion, J. Bai, Bradley J. Monk, L. Robin Keller, E. N. Ramez, G. K. Forde, J. K. Chan and K. S. Tewari

Gynecologic Oncology

03/10/2015

PMID: 25766118

Metrics

7 Record Views

Title: A Markov model to evaluate cost-effectiveness of antiangiogenesis therapy using bevacizumab in advanced cervical cancer
Creators: L. E. Minion (Author)
J. Bai (Author)
Bradley J. Monk (Author) - Creighton University
L. Robin Keller (Author)
E. N. Ramez (Author)
G. K. Forde (Author)
J. K. Chan (Author)
K. S. Tewari (Author)
Additional links: http://doi.org/10.1016/j.ygyno.2015.02.027
Publication Details: Gynecologic Oncology
Publisher: Elsevier Inc
Identifiers: 991005932627802656
Academic Unit: School of Medicine; Obstetrics & Gynecology; General Medicine
Language: English
Resource Type: Journal article